Chile vs Low income: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Chile
- Low income
How they compare
Chile currently reports 26.7% against 10.9% in Low income, a difference of 15.8%.
That makes Chile's figure about 2.5 times Low income's.
Across all 9 years both countries report, Chile has been ahead every year.
Chile ranks 41st and Low income ranks 40th of 166 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Low income | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.8% | 20.2% | 22.6% | Chile |
| 2010s | 35.0% | 15.2% | 19.8% | Chile |
| 2020s | 27.8% | 11.4% | 16.4% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Chile or Low income?
- Chile, at 26.7% against 10.9% in Low income as of 2024.
- What is the difference in prevalence of current tobacco use between Chile and Low income?
- 15.8%, with Chile ahead.
- How many years of comparable data are there for Chile and Low income?
- 9 years are reported by both, from 2000 to 2024.
- How do Chile and Low income rank globally for prevalence of current tobacco use?
- Chile ranks 41st and Low income ranks 40th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.